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L1-CAM belongs to a functionally conserved group of neural cell adhesion molecules that are 
implicated in many aspects of nervous system development. In many neuronal cells the adhesive 
function of L1-type CAMs induces cellular signaling processes that involves the activation of 
neuronal tyrosine protein kinases and among other functions regulates axonal growth and 
guidance. Mutations in the human L1-CAM gene are responsible for a complex 
neurodevelopmental condition, generally referred to as L1 Syndrome. Several pathogenic L1-CAM 
mutations have been identified in humans that cause L1 Syndrome in affected individuals without 
affecting the level of L1-CAM-mediated homophilic cell adhesion when tested in vitro. In this study, 
an analysis of two different pathogenic human L1-CAM molecules indicates that although both 
induce normal L1-CAM-mediated cell aggregation, they are defective in stimulating human EGFR 
tyrosine kinase activity in vitro and are unable to rescue L1 loss-of-function conditions in a 
Drosophila transgenic model in vivo. These results indicate that the L1 Syndrome-associated 
phenotype might involve the disruption of L1-CAM’s functions at different levels. Either by 
reducing or abolishing L1-CAM protein expression, by interfering with L1-CAM’s cell surface 
expression, by reducing L1-CAM’s adhesive ability or by impeding further downstream adhesion-




L1-type neural cell adhesion molecules are widely expressed during metazoan nervous system 
development where it is involved in multiple cellular processes, ranging from neuronal differentiation and 
organization, neurite outgrowth and axonal pathfinding, to synapse formation and maintenance (1-3). 
While non-vertebrate genomes encode only one L1-type protein, gene multiplication events generated 
four different L1-type genes in vertebrate species (referred to as L1-CAM, CHL1, Neurofascin and 
NrCAM)(4). This may have facilitated a functional diversification of these paralogous L1-type proteins, 
including the addition of novel protein-protein interactions. However, several central L1 functions, such 
as the promotion of neurite outgrowth, axonal pathfinding and several cytoplasmic interactions are well 
conserved throughout the entire L1 gene family. One such conserved function is the adhesion-dependent 
activation of neuronal receptor tyrosine kinase receptors (RTKs). Based on their results obtained from in 
vitro experiments Doherty, Walsh and coworkers postulated that in vertebrate neurons L1-CAM-mediated 
adhesion results in the activation of type I FGFR and ultimately in neurite outgrowth (5). Genetic results 
from the Drosophila system indicate that during pupal nervous system development the Drosophila L1-
type protein Neuroglian (Nrg) mediates axonal growth and pathfinding of several sensory neurons 
through the activation of neuronal Epidermal Growth Factor and Fibroblast Growth Factor Receptors 
(EGFR and FGFR) (6). Moreover, human L1-CAM rescues an RTK-mediated axonal growth and 
pathfinding phenotype in the developing Drosophila nervous system that is caused by neuroglian loss-of-
function (LOF) conditions (7).  
LOF conditions for L1-type genes in different species result in pleiotropic phenotypes, ranging from 
late embryonic lethality in Drosophila to mental retardation and neurological malformations in humans 
(8-10). Due to its genomic localization on the X chromosome in mice and humans, pathogenic mutations 
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in the L1-CAM gene exhibit a typical X-linked inheritance in these species (11). As different mutations in 
the human L1-CAM gene exhibit a large phenotypic variance, they were originally reported under various 
designations, such as X-linked hydrocephalus, MASA syndrome, X-linked agenesis of the corpus 
callosum and X-linked spastic paraplegia (12, 13). These allelic disorders are now jointly referred to as L1 
syndrome (1). Whereas all affected male individuals are mentally retarded, other neurological L1-
associated phenotypes, such as hydrocephalus, agenesis of the corticospinal tract and the corpus callosum 
and clasp thumbs, exhibit variable penetrance and expressivity (14). The expression of these phenotypic 
traits not only depends on the type of molecular lesion and how it affects the expression and functionality 
of the L1-CAM protein, but likely appears also to be under considerable epigenetic control. Well over 180 
pathogenic mutations in the human L1-CAM gene have been analyzed at the DNA level. Many of these 
mutations cause major deletions or a premature termination of the L1-CAM protein. However, about one 
third of affected families have single missense mutations in the L1-CAM gene, which alters only one of 
the 1257 amino acid residues of the human neuronal L1-CAM protein. These pathogenic missense 
mutations are scattered over the entire length of the human L1-CAM protein implicating different L1-
dependent functions in the pathophysiology of L1 Syndrome. In general, carboxy-terminal mutations, 
which affect the cytoplasmic protein domain, exhibit a milder phenotype (15, 16). Whereas many 
pathogenic L1-CAM mutations interfere with the protein’s homo- or heterophilic adhesive function or 
result in defective protein trafficking, other L1-CAM missense mutations have been shown to mediate 
normal adhesion in various in vitro assay systems (14, 17-21). These results indicate that functions other 
than homophilic adhesion might also contribute to the observed neurological defects in individuals with 
L1 syndrome.  
Many molecular, as well as the developmental functions of human L1-CAM can be efficiently tested in 
Drosophila assay systems. E.g., wild type human L1-CAM rescues the Drosophila L1-type protein nrg 
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LOF phenotype in ocellar sensory neurons (7). Therefore, the fly can be used as a simple test system for 
probing the axonal growth and pathfinding function of L1-type proteins in vivo. In this study we analyzed 
the functional capacity of two pathogenic human L1-CAM proteins (E309K alias H38 and Y1070C alias 
H1, Fig. 1), for which normal homophilic adhesion has previously been reported (17-19), to mediate 
downstream L1-CAM-dependent interactions and functions. The two amino acid residues that are affected 
by the H38 and the H1 mutation (E309 and Y1070) are both predicted to reside on the surface of their 
respective L1-CAM protein domain (22). Although these residues are not conserved in the Drosophila 
Neuroglian protein (T314 and E1072), both human mutations change the chemical nature of these amino 
acid residues considerably, either by introducing a positive charge (H38 E309K) or by introducing a 
protein surface exposed cysteine residue (H1 Y1070C). These changes may well interfere with L1-CAM 
protein-protein interactions and/or with the structural dynamics of the L1-CAM protein. Based on our 
previous observations that L1-CAM adhesion activates the EGFR kinase (23) and that this interaction 
regulates axonal growth and pathfinding in the developing Drosophila nervous system in vivo (6, 7), we 
investigated the functional capacity of these two mutant proteins to induce EGFR activity in a cell-based 
assay system and to rescue L1 LOF conditions in developing sensory neurons in vivo. We found that both 
pathogenic human L1-CAM proteins were fully competent to mediate homophilic cell adhesion in 
Drosophila cells, but exhibited a lower than wild type ability to activate EGFR signaling and failed to 
rescue L1-deficient conditions in vivo. These results indicate that L1-CAM functionality during early 
nervous system development can be disrupted at different levels, firstly by deleting or truncating the L1-
CAM protein, thereby creating protein null conditions; secondly by mutations that interfere with the 
proper cell surface expression of the L1-CAM protein; thirdly by mutations that diminish the adhesive 
properties of the protein; and lastly by compromising molecular interactions that act downstream of L1-
CAM-mediated adhesion, such as the activation of neuronal signaling processes.  
6 
RESULTS 
The pathogenic human H1 and H38 L1-CAM proteins mediate normal homophilic adhesion in 
Drosophila S2 cells 
We first tested whether the H1 and H38 pathogenic L1-CAM proteins can be stably expressed by 
Drosophila Schneider 2 (S2) cells and whether these missense mutant L1-CAM proteins mediate wild 
type levels of homophilic cell aggregation as had previously been reported in mammalian tissue culture 
cells (17, 18). The H38 protein has a single lysine for glutamate change at position 309 in the third 
immunoglobulin domain of L1-CAM, whereas the H1 mutation results in a cysteine for tyrosine change at 
position 1070 in the fifth fibronectin type III domain. cDNAs encoding the neuronal isoform of wild type 
or the two mutant forms of human L1-CAM were transfected into and expressed in Drosophila S2 cells. 
As shown in Fig. 2A, following overnight induction of cDNA expression wild type and mutant L1-CAM 
proteins were stably expressed in Drosophila S2 cells with an expected molecular weight of 
approximately 200 kDa (24). Furthermore, unlike untransfected S2 cells that did not adhere to each other 
transfected S2 cells expressing wild type of H1 or H38 mutant L1-CAM proteins over time formed robust 
cell aggregates (Fig. 2B-E). A quantitative analysis of S2 cell aggregation based on four independent 
experiments demonstrated that both H1 and H38 mutant L1-CAM protein mediate homophilic S2 cell 
aggregation to the same level as the wild type protein (Fig. 2F). This finding in Drosophila cells agrees 
with previous analyses using COS-7 and CHO cells, which also reported normal homophilic adhesion 
levels for these pathogenic mutant L1-CAM proteins (17, 18).  
Both H1 and H38 mutant L1-CAM proteins have a reduced ability to induce EGFR kinase activity 
L1-type CAMs control neuronal development through their functional interactions with tyrosine 
kinase-regulated signaling pathways (1). We previously established and characterized an S2 cell assay to 
demonstrated that homophilic L1-CAM adhesion triggers EGFR tyrosine kinase activity (23) and genetic 
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data are consistent with this interaction regulating axonal growth and guidance in Drosophila sensory 
neurons (6, 7). To evaluate the ability of the H1 and H38 L1-CAM proteins to induce the adhesion-
dependent activation of human EGFR, we generated double-transfected S2 cell lines, in which wild type, 
H1 or H38 L1-CAM or Drosophila Fasciclin I was co-expressed with human EGFR. Drosophila Fasciclin 
I was used as a negative control as it has no reported functional interaction with the EGFR signaling 
pathway (23). The Western blot analyses shown in Fig. 3A and B demonstrate that human L1-CAM and 
EGFR proteins are stably expressed in induced S2 cells. For the analysis of EGFR tyrosine kinase 
activation, protein production was induced overnight and cells were briefly aggregated to generate small 
cell clusters, which were subsequently processed for immunocytochemistry with anti-phosphotyrosine 
antibodies. As previously reported (23), fluorescence staining indicating protein tyrosine phosphorylation 
of EGFR molecules was mainly restricted to cell contact areas. Individual cell-cell contact sites were 
carefully analyzed and scored by confocal microscopy. A quantitative analysis of four independent 
experiments using two independent transfected cell lines for each vector combination demonstrated a 
statistically significant reduction of EGFR activation for the H1 and H38 L1-CAM proteins (22% and 
23% respectively) when compared to wild type L1-CAM protein (34%) (Fig. 3R). The Drosophila 
Fasciclin I induced a positive phosphotyrosine signal at only 2% of all cell-cell contacts. These results 
indicate that the ability of the H1 and H38 proteins to activate EGFR kinase signaling is not abolished, but 
significantly reduced, which may have physiological consequences under in vivo conditions.  
Expression of human L1-CAM proteins in Drosophila tissues 
In order to investigate the functional ability of mutant human H1 and H38 L1-CAM proteins under in 
vivo conditions, we generated several independent Drosophila UAS-GAL4-inducible transgenic lines (25) 
for both human mutant L1-CAM proteins. Drosophila transgenic lines with a functional UAS-wt human 
L1-CAM insert had previously been generated and characterized (7). These lines were used to ascertain 
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the expression and cell surface expression of human L1-CAM proteins in Drosophila tissues. Using 
Western blot analysis we found that wild type, as well as mutant L1-CAM proteins were expressed in 
Drosophila tissues with the expected molecular weight of 200 kDa (Fig. 4A). The in vivo analysis of the 
cell surface expression of human L1-CAM proteins in imaginal disk epithelia in vivo, was analyzed by 
immunocytochemistry using anti-L1-CAM antibodies and revealed that wild type and H1 proteins are 
expressed on the cell surface and at cell-cell contact regions in wing (Fig. 4B and C). In contrast, L1-
CAM immunostaining for the H38 protein showed an accumulation of mutant H38 protein inside 
imaginal disk epithelial cells. This is not a surprising finding as H38 and other mutant L1-CAM proteins 
have previously been associated with intracellular trafficking defects and reduced cell surface expression 
(17-19, 21). 
Pathogenic mutant L1-CAM proteins fail to rescue nrg LOF conditions in Drosophila sensory 
neurons 
Many lines of evidence suggest that L1-type CAMs regulate axonal growth and pathfinding through 
the activation of neuronal tyrosine kinase signaling, including fibroblast growth factor receptor (FGFR), 
EGFR and some non-receptor tyrosine kinases (1). As several traits of L1 syndrome, e.g., agenesis of the 
corticospinal tract and the corpus callosum, might be caused by a dysfunction of this developmental L1-
CAM function, we tested the ability of H1 and H38 mutant L1-CAM proteins to sustain axonal growth 
and guidance in vivo. We previously reported that ectopic expression of wild type human L1-CAM 
rescues the nrg LOF phenotype in bristle mechanosensory (BM) and ocellar pioneer (OP) neurons, which 
constitute the ocellar sensory system (OSS) of the fly (7). This biological function involves the L1-
dependent activation of neuronal RTK activity (6). As the L1- and the NCAM-type CAMs Neuroglian 
and Fasciclin II are co-expressed in OP neurons and exhibit an RTK-dependent functional redundancy 
during axonal growth and pathfinding (7), we focused our analysis on the functional capacity of H1 and 
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H38 mutant proteins to rescue nrg LOF conditions in BM neurons, where Fasciclin II is not expressed. In 
wild type animals, the ocellar BM fascicle contains converging axons from the single ocellar bristle and 
the ocellar microchaetes. Further anterior the BM fascicle converges with the orbital bristle nerve (Fig. 
5A). A loss of the endogenous L1-type Nrg protein during OSS development often results in a stalling 
phenotype and less frequently in misguidance defects of ocellar and orbital BM axons (see Fig. 5B). 
Sometimes only one or a subset of axons seem to stall within a nerve, while other axons extend normally 
(see the white arrowhead in Fig. 5B). As this situation can not always be distinguished from an abnormal 
thickening of axons, which is sometimes observed, only phenotypes in which all axons stopped growing 
were counted (see black arrowheads in Fig. 5B, D and E). In a few cases (<20% of phenotypic heads), 
BM axons separated from the epidermis without connecting with the orbital nerve or projected backwards 
or to an ectopic place. These cases were included in the quantitative evaluation that is presented in Table 
1. The ectopic expression of wild type and mutant human L1-CAM protein in a wild type background 
results in a low, but not significant level (4-11%) of BM axonal defects. When the endogenous 
Drosophila L1-type CAM, Nrg, was removed using the temperature-sensitive nrg3 allele, BM axon 
defects were observed in 34% of all heads. Consistent with our previous results (7), the ectopic expression 
of wild type human L1-CAM in these nrg LOF animals resulted in a statistically highly significant 
reduction of the BM phenotype. In contrast to wild type L1-CAM, the expression of H1 or H38 mutant 
L1-CAM protein did not rescue the nrg3 phenotype and the penetrance level of BM axon defects appeared 
to be additive from the nrg3 LOF and the human L1-CAM misexpression phenotype.  
DISCUSSION 
The variety of L1-CAM-associated developmental functions and the multitude of L1-interacting 
ligands correspond with the complexity of the L1 LOF phenotype in humans and in various model 
systems. Due to a strong epigenetic influence on the penetrance and the expressivity, L1-associated 
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phenotypes are highly variable. Therefore, it is difficult to equate specific molecular properties of L1-type 
CAMs or the lack thereof with experimental results obtained from in vitro test systems or with specific 
mutation-induced dysfunctions in vivo. As a consequence, it has remained unclear, why certain missense 
mutations in the human L1-CAM protein exhibit normal adhesive properties in vitro, but induce 
neurological abnormalities that overlap with those caused by protein null conditions. In this publication 
we demonstrate that two human pathogenic L1-CAM proteins maintain their homophilic adhesiveness, 
but are deficient in vitro, as well as in vivo in a further downstream function, the adhesion-dependent 
induction of RTK tyrosine kinase activity. 
As extra- and intracellular domains of L1-type proteins associate with a wide range of different protein 
ligands, heterophilic interactions might influence the expression of the L1 Syndrome phenotype. De 
Angelis et al. analyzed the ability of H1 and H38 mutant L1-CAM protein to bind to two GPI-anchored, 
immunoglobulin-domain CAMs, Contactin/F11/F3 and TAG-1/Axonin-1. Both these Ig-domain CAMs 
are widely expressed in the developing nervous system where they mediate homophilic cell adhesion and 
also interact with L1-type proteins (26). Using a cell-free microsphere bead assay, De Angelis et al. (17, 
18) reported that the H38 L1-CAM protein has a reduced ability to interact with Contactin/F11 and TAG-
1/Axonin-1. In contrast, they found that H1 L1-CAM protein exhibited an increased binding affinity for 
F11 and Axonin-1 isolated from chicken brain (17), but interacted at wild type levels with human TAG-1 
(18). However, these results do not reveal how L1-CAM’s interactions with GPI-anchored CAMs might 
be compromised by the H1 and the H38 mutation and whether these interactions contribute to the 
phenotypic manifestations of L1 Syndrome. The recent analyses of Contactin and TAG-1 knockout mice 
show no phenotypic overlap with L1-CAM mutations and therefore argue against a significant 
involvement of these heterophilic L1 ligands in the generation of the L1-CAM LOF phenotype. In TAG-
1-deficient mice the gross anatomy of the nervous system is normal, but these mice exhibit a greater 
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sensitivity to convulsant stimuli (27). In addition, TAG-1 is important for the organization of 
juxtaparanodal regions at nodes of Ranvier (28, 29). The lack of this TAG-1 function is likely responsible 
for the impairment of cognitive functions and the reduction in motor activity that is observed in TAG-1 
knockout mice (30). Mice lacking a functional contactin gene develop cerebellar defects, which result in a 
severe ataxia and death by postnatal day 18 (31). Similar to TAG-1, Contactin is also involved in 
establishing functional paranodal junctions and is specifically important for the localization of Kv1.1 and 
1.2 potassium channels at the nodes of Ranvier (32). The interaction between Contactin- and L1-type 
proteins at septate-type junctions is evolutionary well conserved (33) and has also been described in 
Drosophila epithelia and at neuron-glia cell contacts (34). However, as L1-CAM is not expressed at nodes 
of Ranvier in humans, this L1 function is not carried out by L1-CAM in mammalian species, but rather by 
its paralogs NrCAM and Neurofascin (35). The lack of phenotypic overlap between L1-CAM, Contactin 
and TAG-1 and the limited co-expression argues against a major contribution of these heterophilic L1-
CAM ligands to the L1-CAM LOF phenotype.  
Originally LOF conditions for L1-CAM in humans were described as four distinct disorders, which had 
only a limited phenotypic overlap (13). The expression of different phenotypic traits in humans with L1-
CAM mutations is rather complex. Even within families that shares a common L1-CAM mutation, the 
expressivity of various phenotypic traits differ considerably between affected individuals (14, 36). A 
strong influence of the genetic background on phenotype expression has also been confirmed in L1-CAM 
knockout mouse strains (37, 38). Overall the L1-CAM knockout phenotype in mice resembles that of 
humans with L1-CAM mutations. It includes corticospinal defects, enlarged ventricles causing 
hydrocephalus, impaired locomotive functions, agenesis of the corpus callosum, hippocampal defects, a 
reduction in Schwann cell-axon interactions, a misorganization of dopaminergic neurons in the mouse 
mesencephalon and abnormal retinocollicular projections (10, 37, 39-45). Several of these traits, like the 
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hypoplasticity of the corticospinal tract and malformations of ventricular structures resulting in 
hydrocephaly, are highly dependent on the genetic background (37, 38). Interestingly, the importance of 
the genetic background for the penetrance and expressivity of the L1-CAM knockout phenotype is 
reminiscent of the situation described for knockout conditions of the mouse EGFR gene (46). 
Different functional aspects of L1 gene family biology may contribute to the complexity of the 
observed L1 LOF phenotype. In vertebrate species, this complexity is increased by the expression of four 
L1-type genes (4). These paralogous L1-type genes and their protein products exhibit a significant overlap 
in their patterns of expression and their biological functions (4). As demonstrated by Sakurai et al., these 
overlaps result in a genetic redundancy between different L1-type genes, which is only uncovered in 
multiple gene knockout animals (47). Furthermore, even in species with only a single L1-type gene, such 
as Drosophila, a functional redundancy between Neuroglian and the NCAM-type Fasciclin II protein has 
been reported (7). These functional and molecular redundancies make it very difficult to pinpoint specific 
molecular functions such as L1-CAM’s homophilic adhesion, as being responsible or dispensable for 
specific phenotypic traits.  
The finding that certain human pathogenic L1-CAM mutations maintain their full homophilic binding 
ability can be interpreted in two ways. First, that L1-CAM-mediated homophilic adhesion has no or only 
a limited importance for L1-CAM function. In support of this argument, Itoh et al. reported that some 
phenotypic traits in an L1-CAM knockout mouse were “rescued” by a homophilic adhesion-dead form of 
L1-CAM (38). Alternatively, L1-dependent processes that are downstream of its adhesive function may 
be specifically affected in these L1-CAM mutations. As sensory axon growth and guidance in the 
Drosophila ocellar system is regulated by the L1-mediated activation of neuronal RTKs (6, 7), we tested 
this possibility by analyzing the ability of two mutant human L1-CAM proteins, H1 and H38, to activate 
EGFR signaling in vitro and to rescue the L1 LOF phenotype in vivo (Table 2). Both proteins can be 
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stably expressed in Drosophila tissues and mediate a wild type level of homophilic cell adhesion in S2 
cells. However, the H38 protein also exhibits an abnormal intracellular location in Drosophila epithelial 
cells, indicating that its transport to the cell surface is impeded. Nevertheless, sufficient H38 protein 
reaches the cell surface to mediate a wild type level of cell adhesion in S2 cells. Using an S2 cells EGFR 
activation assay, we found that both mutant L1-CAM proteins display a reduced ability to activate EGFR 
tyrosine kinase activity when compared to their wild type counterpart. This in vitro result was confirmed 
by the inability of both mutant proteins to rescue LOF conditions for the Drosophila L1-type Neuroglian 
protein in vivo. Axonal growth and guidance of ocellar BM neurons depend on the L1-mediated activation 
of RTKs (6, 7). Similar to the situation in the Drosophila ocellar sensory system, axonal growth and 
misguidance defects have been reported as the cellular consequences for some of the phenotypic traits in 
L1-CAM knockout mice, specifically the agenesis of the corpus callosum and the corticospinal tract (39, 
42). Doherty and Walsh demonstrated previously that the L1-CAM-mediated activation of neuronal type 
1 FGFRs is an important mechanism to induce neurite outgrowth in vertebrate neurons (5). This L1 
function appears to be well-conserved throughout evolution and governs some aspects of Drosophila 
nervous system development. We have shown that human L1-CAM synergistically activates Drosophila 
FGFR and EGFR activity to regulate axonal growth and guidance in Drosophila sensory neurons (7). This 
indicates that the functional interaction between L1-type CAMs and neuronal RTKs constitutes an 
important functional L1 attribute in vivo. However, how much this L1 function and specifically the 
activation of EGFR contributes to the L1-CAM LOF phenotype in mice and humans is currently unknown 
and other signaling processes that are downstream of L1-CAM’s hetero- and homophilic interactions may 
also exert an important influence on phenotypic expressivity. One such heterophilic interaction is the 
more recently described interaction between L1-CAM and the Semaphorin3A co-receptor Neuropilin-1 
(48) and the reported dependency of Semaphorin3A signaling on L1-CAM expression (49). However, 
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similar to TAG-1 and Contactin, Semaphorin3 knock out mice exhibit little phenotypic overlap in 
comparison with L1-CAM knock out mouse lines (50, 51). 
Accumulating evidence from several laboratories indicates that mutations in the L1-CAM gene/protein 
interfere with L1-CAM function at different levels. Many frame shift, nonsense and splice mutations 
create a non-function L1-CAM protein fragment and are therefore the equivalent of a protein null 
mutation. A second level of interfering with L1-CAM function is the aberrant cellular localization of L1-
CAM protein, which has been reported for several L1-CAM point mutations (20, 21). As reported here, 
this appears to be at least in part the case for the human H38 protein. Other mutant proteins are correctly 
transported to the neuronal cell surface, but are unable to fully engage in homo- and/or heterophilic 
interactions (17, 18). In this report we present evidence that L1-CAM functions downstream of its 
adhesive interactions might also be disabled in pathogenic mutant L1-CAM proteins and result in a 
specific phenotype. We previously demonstrated that homophilic L1-CAM interactions induce EGFR 
tyrosine kinase activity (23) and that this L1 function is well conserved between Drosophila Neuroglian 
and human L1-CAM (7). However, we cannot exclude that under in vivo conditions, other heterophilic L1 
interactions also contribute to RTK activation and that pathogenic L1-CAM mutations also affect other, 
RTK-independent downstream interactions to cause some of the L1-associated phenotypic traits. 
MATERIAL AND METHODS 
Generation of plasmid vectors encoding mutant human L1-CAM proteins 
cDNA clones encoding the entire open reading frame of the neuronal isoform of mutant human L1-CAM 
proteins were provided by Drs. S. Kenwrick, T. Brümmendorf and F. Rathjen (17, 18). The cDNA inserts 
were partially sequenced to verify the presence of the H1 and the H38 mutation, respectively. 
Subsequently, they were subcloned into the pRmHa-3 vector for the S2 cell transfection experiments and 
into the pUAST vector for the generation of transgenic Drosophila lines.  
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S2 cell transfection, protein expression and adhesion assays 
S2 cells were kept in SFX HyQ Insect medium (Fisher Scientific, Pittsburgh, PA) without fetal calf 
serum, but with penicillin/streptomycin (Life Technologies Corp., Carlsbad, CA). Cell transfection using 
Lipofectin® (Life Technologies Corp., Carlsbad, CA) and selection of transfected cell line using 
hygromycin resistance were preformed as previously described (23). For the quantitative aggregation 
assay, transfected S2 cells were induced overnight with 0.7 mM CuSO4, mechanically dissociated and 
incubated in a 50 ml test tube on a shaking platform at 200 rpm. Using a hemocytometer, cell aggregation 
was quantified by determining the single cell concentration after 8 hours of incubation. Data points in Fig. 
2F represent the average of 4 independent experiments. Cell aggregation and subsequent immunostaining 
with the phosphotyrosine-specific mAb PY20 was performed as outlined by Islam et al. (23). 
SDS-PAGE, antibodies, Western blot analysis and immunostaining procedures 
Proteins were separated in standard 10% SDS-PAGE gels and blotted onto Immobilon-P PVDF 
(Millipore Corp., Billerica, MA) or BioTrace™ nitrocellulose membranes (Pall Corp., East Hills, NY). 
Protein concentrations were determined using the BCA Protein Assay kit from Pierce Biotechnology Inc. 
(Rockford, IL). Goat anti-L1-CAM and anti-EGFR polyclonal antisera were purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA). Anti-β-actin and anti-phosphotyrosine PY20 mAbs were from 
Sigma-Aldrich (St. Louis, MO) and from Cell Signaling Technology (Danvers, MA), respectively. The 
Drosophila Fasciclin I-specific 5H7 mAb has been described by Hortsch et al. (52). For Western blot 
analyses mAb ascites fluid was used at an 1:500 dilution, commercial polyclonal antisera  at 1:300) and 
anti- β-actin antibody at 1:10000. HRP-, and FITC-labeled secondary antibodies were from Jackson 
ImmunoResearch Laboratories Inc. (West Grove, PA) and were used at an 1:2000 dilution for Western 
blot analysis and at 1:200 for immunocytochemistry. Bound primary antibodies on Western blots were 
visualized using the ECL Western blot detection kit from Amersham Pharmacia Biotech (now part of GE 
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Healthcare, Chalfont St. Giles, UK). 3,3’-diaminobenzidine-based immunostainings of pupal heads with 
the 22C10 mAb were carried out as previously described (6). The VectastainABC kit from Vector 
Laboratories Inc. (Burlingame, CA) was used to enhance the signal. Images of processed S2 cells and 
Drosophila imaginal disks were captured with a Nikon Optiphot 2 microscope (Nikon Corp., Tokyo, 
Japan) that is equipped with Nomarski optics and a Nikon DXM1200 digital camera system or using a 
Olympus FV confocal scanning laser microscope (Center Valley, PA), which is housed in the Microscope 
Imaging Laboratory at the University of Michigan. Images of stained Drosophila heads were captured 
using an Eclipse 80i Nikon microscope with Nomarski optics and a Nikon DS-5M-L1 digital camera 
system. 
Drosophila lines and in vivo expression of transgenic human L1-CAMs 
Multiple transgenic lines were produced by microinjection of plasmid DNA into w1118 Drosophila 
embryos and the subsequent selection of w+ positive animals for each pUAST-mutant L1-CAM construct. 
Transgenic lines encoding wild type human L1-CAM under UAS control have been described and were 
used in earlier publications (7, 23). The MS1075 GAL4 driver line was previously characterized by 
Garcia-Alonso et al. (6) and used for nrg LOF rescue experiments by Kristiansen et al. (7). All fly lines 
except the nrg3 line were maintained and all experiments were performed at 25° C. The temperature-
sensitive nrg3 allele was maintained at 18° C and shifted to 29° C as the non-permissive temperature (53). 
Details about the temperature shift experiments and the immunocytochemical staining procedure using the 
22C10 mAb for the visualization of axonal pathway formation in the ocellar system have been published 
previously (6, 7). The statistical analysis of the S2 cell experiments was performed using a Welch’s t-test 
comparison for two independent samples and the two-tailed Fisher exact test was used for the analysis of 
the genetic experiments. The analysis in Table 1 represents the pooled results from two independent 
transgenic lines for each of the different constructs.  
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Figure 1. Protein domain model of the L1-CAM protein indicating the positions of the H1 and H38 
missense mutations. 
 
Figure 2. Mutant H1 and H38 human L1-CAM protein both mediate wild type level homophilic cell 
aggregation in Drosophila S2 cells. Panel A depicts a Western blot of total S2 cell proteins that were 
isolated from the transfected S2 cell lines and subsequently tested for homophilic cell aggregation (see 
panels B to F). Panels B to E show untransfected (B) or transfected S2 cells that express wild type (B) or 
mutant (D - H1 and E - H38) human L1-CAM protein. The images show the presence of typical S2 cell 
aggregates for S2 cells expressing wild type or mutant human L1-CAM. The size bar corresponds to 
100µm. Panel F depicts the quantification of homophilic S2 cell aggregation that is induced by the 
expression of the different human L1-CAM proteins. Shown are the results of 5 independent experiments. 
Compared to untransfected S2 cells p-values were calculated for wild type L1-CAM transfected S2 cells 
as p=1.3x10-4, for H1 transfected S2 cells as p=0.5x10-4, and for H38 transfected S2 cells as p=5.5x10-4. 
 
Figure 3. Quantitative evaluation of the ability of wild type and mutant human L1-CAM proteins to 
induce human EGFR tyrosine kinase activity at S2 cell-cell contact sites. Panels A, B and C represent 
Western blots of total protein extracts (50 µg per lane) from induced untransfected (lanes 1) or transfected 
(lanes 2 to 5) S2 cells. Blot A was incubated with anti-L1-CAM, blot B with anti-EGFR and blot C with 
anti-β-actin antibodies, respectively, and developed with ECL reagent after an incubation with HRP-
labeled secondary antibodies. Panels D to P show confocal microscopy images of small S2 cell aggregates 
that were incubated with an anti-phosphotyrosine antibody probe. S2 cells in panels D to F co-express 
wild type human L1-CAM and EGFR, panels G to I mutant H1 L1-CAM and wild type human EGFR, 
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panels K to M mutant H38 L1-CAM and wild type EGFR and panels N to P Drosophila Fasciclin I 
protein with wild type human EGFR. The scale bar represents 20µm. Panel R depicts a quantitative 
analysis of cell contacts staining for phosphotyrosine for the four different cell lines depicted in the 
previous panels. These results were obtained from 4 separate experiments using 2 independently 
transfected S2 cell lines for each construct. At least 100 cell-cell contacts were evaluated per experiment 
for each transfected cell line. In comparison to wild type L1-CAM transfected cells p=values were 
calculated for H1 transfected cells as p=2.8x10-2, for H38 transfected cells as p=3.6x10-2 and for Fasciclin 
I transfected cells as p=0.3x10-2. 
 
Figure 4. Expression of wild type and mutant human L1-CAM in Drosophila imaginal disks. Panel A 
shows the result of a Western blot Drosophila total protein (50 µg total protein per lane) that was 
incubated with anti-L1-CAM antibodies. Panels B to D show that expression of human L1-CAM proteins 
in Drosophila wing imaginal disks. Panel B depicts the expression from a wild type human L1-CAM 
gene, whereas panels C and D show expression of the H1 and H38 mutant human L1-CAM proteins in 
wing imaginal disks, respectively. The inserts show sections of imaginal disk epithelia at a higher 
magnification. The scale bar represents 20 µm for the main images and 8 µm for the inserts. 
 
Figure 5. Neuroglian LOF phenotype in the adult Drosophila ocellar system and rescue by transgenic 
wild type human L1-CAM. Panel A depicts the ocellar system of a wild type fly. Neuronal cell bodies and 
axons were visualized by immunostaining with 22C10 antibody. Panel B shows the head of an nrg3 
mutant fly that was incubated at non-permissive temperature during pupal development. The black 
arrowheads indicate a complete stalling phenotype of a BM axonal pathway, whereas the white arrowhead 
marks a partial stalling phenotype (not considered for data quantification). Panel C shows an example of 
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the nrg LOF phenotype that was rescued by human L1-CAM expression, whereas panels D and E show a 




Table 1. Quantitative evaluation of the BM axonal stalling phenotype in wild type or nrg LOF 
Drosophila heads that express wild type or mutant human L1-CAM, respectively. 






























BM bristle mechanosensory; CAM cell adhesion molecule; CHL1, close homologue of L1; EGFR 
epidermal growth factor receptor; FGFR fibroblast growth factor receptor; HRP horseradish peroxidase; 
LOF loss-of-function; MASA mental retardation, aphasia, shuffling gait, and adducted thumbs; NrCAM 
Ng-CAM related cell adhesion molecule; OP ocellar pioneer; OSS ocellar sensory system; RTK receptor 
tyrosine kinase; UAS universal activator sequence 
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